Back

Factor XI inhibition – the new paradigm for atrial fibrillation and stroke

16 April 2023 (15:00 - 15:15)
Organised by:
Congress Presentation Part of: The new frontier in oral anticoagulation: Factor XIa inhibitors Stroke Prevention EHRA Premium Access EHRA 2023

About the speaker

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
This programme is supported by Bayer Pharma AG in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor
Slides
Presentation thumbnail
Non-vitamin K antagonist oral anticoagulants (NOACs) – Limitations and new opportunities
Professor J. Steffel (Zurich, CH)
Slides Video
Presentation thumbnail
Factor XI inhibition – are NOACs obsolete? Mechanistic and pharmacological insights
Doctor J. Weitz (Hamilton, CA)
Slides Video
Presentation thumbnail
Factor XI inhibition – other indications: acute coronary syndrome, venous thromboembolism
Professor D. Capodanno (Catania, IT)
Slides Video

Access the full session

Session thumbnail
The new frontier in oral anticoagulation: Factor XIa inhibitors
Video

The Event

Event poster

EHRA 2023

16 April 2023 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation
26 August 2023
thumbnail
Congress Presentation
Stroke
26 August 2023
thumbnail
Congress Presentation
Discussant review - AXIOMATIC-SSP.
28 August 2022
thumbnail
Congress Presentation
Anticoagulation in frail patients with atrial fibrillation
14 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources